These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 38603649)
21. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics. Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930 [TBL] [Abstract][Full Text] [Related]
22. Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA. Cortes-Ciriano I; Steele CD; Piculell K; Al-Ibraheemi A; Eulo V; Bui MM; Chatzipli A; Dickson BC; Borcherding DC; Feber A; Galor A; Hart J; Jones KB; Jordan JT; Kim RH; Lindsay D; Miller C; Nishida Y; Proszek PZ; Serrano J; Sundby RT; Szymanski JJ; Ullrich NJ; Viskochil D; Wang X; Snuderl M; Park PJ; Flanagan AM; Hirbe AC; Pillay N; Miller DT; Cancer Discov; 2023 Mar; 13(3):654-671. PubMed ID: 36598417 [TBL] [Abstract][Full Text] [Related]
23. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations? Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495 [TBL] [Abstract][Full Text] [Related]
25. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee. Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612 [TBL] [Abstract][Full Text] [Related]
26. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228 [TBL] [Abstract][Full Text] [Related]
27. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors. Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165 [TBL] [Abstract][Full Text] [Related]
28. [A rare case of nerve-sheath sarcoma with rhabdomyoblastic differentiation (malignant triton tumor)]. Malerba M; Garofalo A Tumori; 2003; 89(4 Suppl):246-50. PubMed ID: 12903608 [TBL] [Abstract][Full Text] [Related]
29. Recurrent chromosomal imbalances and structurally abnormal breakpoints within complex karyotypes of malignant peripheral nerve sheath tumour and malignant triton tumour: a cytogenetic and molecular cytogenetic study. Bridge RS; Bridge JA; Neff JR; Naumann S; Althof P; Bruch LA J Clin Pathol; 2004 Nov; 57(11):1172-8. PubMed ID: 15509679 [TBL] [Abstract][Full Text] [Related]
30. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification. de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267 [TBL] [Abstract][Full Text] [Related]
31. Low mutation burden and frequent loss of CDKN2A/B and SMARCA2, but not PRC2, define premalignant neurofibromatosis type 1-associated atypical neurofibromas. Pemov A; Hansen NF; Sindiri S; Patidar R; Higham CS; Dombi E; Miettinen MM; Fetsch P; Brems H; Chandrasekharappa SC; Jones K; Zhu B; Wei JS; ; ; Mullikin JC; Wallace MR; Khan J; Legius E; Widemann BC; Stewart DR Neuro Oncol; 2019 Aug; 21(8):981-992. PubMed ID: 30722027 [TBL] [Abstract][Full Text] [Related]
32. Malignant Peripheral Nerve Sheath Tumor in an Army Reservist With Neurofibromatosis Type 1. Kou CJ; Rendo M; Broadwater DR; Beeler B Mil Med; 2021 May; 186(5-6):e626-e631. PubMed ID: 33180928 [TBL] [Abstract][Full Text] [Related]
33. Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression. Mitchell DK; Burgess B; White EE; Smith AE; Sierra Potchanant EA; Mang H; Hickey BE; Lu Q; Qian S; Bessler W; Li X; Jiang L; Brewster K; Temm C; Horvai A; Albright EA; Fishel ML; Pratilas CA; Angus SP; Clapp DW; Rhodes SD Clin Cancer Res; 2024 Mar; 30(5):1038-1053. PubMed ID: 38127282 [TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. McPherson JR; Ong CK; Ng CC; Rajasegaran V; Heng HL; Yu WS; Tan BK; Madhukumar P; Teo MC; Ngeow J; Thike AA; Rozen SG; Tan PH; Lee AS; Teh BT; Yap YS Cancer Med; 2015 Dec; 4(12):1871-8. PubMed ID: 26432421 [TBL] [Abstract][Full Text] [Related]
35. Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs. Miller DT; Cortés-Ciriano I; Pillay N; Hirbe AC; Snuderl M; Bui MM; Piculell K; Al-Ibraheemi A; Dickson BC; Hart J; Jones K; Jordan JT; Kim RH; Lindsay D; Nishida Y; Ullrich NJ; Wang X; Park PJ; Flanagan AM Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32252413 [TBL] [Abstract][Full Text] [Related]
36. [Malignant peripheral nerve sheath tumor: a clinicopathological analysis]. Peng W; Gong QX; Fan QH; Liu Y; Song GX; Wei YZ Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):924-930. PubMed ID: 37670622 [No Abstract] [Full Text] [Related]